It has been shown that the administration of SAHA to wild type and R6/2 mice decreased HDAC2 and HDAC4 at the protein but not RNA levels in different brain regions in vivo (Mielcarek et al., 2011), supporting previous observations from cancer cell lines (Scognamiglio et al., 2008). The gene discussed is HDAC4; the disease is cancer.